Epithelial ingrowth is a complication specific to flap-based LASIK — corneal surface cells migrate under the LASIK flap into the flap-stromal interface. It cannot occur with flapless procedures like SMILE Pro. Published incidence: 0.2–3.9% for primary LASIK; up to 18–19% for re-treatment LASIK where the healed flap is re-lifted. This guide explains the three grades, risk factors, warning signs vs normal healing, diagnosis, and treatment with verified adjuvant therapies.
Key Takeaways
- Epithelial ingrowth is a flap-specific complication — it cannot occur with SMILE Pro or Trans-PRK because there is no flap-stromal interface for cells to migrate into.
- Published incidence: 0.2–3.9% for primary LASIK; rates rise to up to 18–19% for re-treatment/enhancement LASIK where the healed flap is re-lifted and the interface re-exposed.
- A 3-grade classification system guides treatment — Grade 1 (peripheral, non-progressive) requires only monitoring; Grades 2–3 (visual axis involvement or flap distortion) require surgical intervention.
- EBMD (Epithelial Basement Membrane Dystrophy) is the most significant pre-existing patient risk factor — weak epithelial adhesion increases cell seeding at the interface during flap creation.
- Treatment: flap lift and debridement + adjuvant therapies (ethanol, MMC, fibrin glue) — to eliminate cells and reduce recurrence.
- Recurrence is common — published series: 6–68% depending on technique and adjuvants. Close post-treatment follow-up is non-negotiable.
What Is Epithelial Ingrowth After LASIK?
In LASIK, a flap is cut through the corneal epithelium into the stroma. When the flap is lifted, epithelial cells can seed the interface. If these cells proliferate rather than being cleared, they grow between the flap and the stromal bed — this is epithelial ingrowth.
Most cases are mild and non-progressive. The clinical concern is when ingrowth encroaches on the visual axis, causes irregular astigmatism, or — in severe cases — triggers flap melt (enzymatic digestion of the overlying stroma). Regular slit lamp follow-up catches this early, often before the patient notices symptoms.
This is unique to flap-based procedures — flapless procedures (SMILE Pro, Trans-PRK) eliminate this risk. Our guide on Diffuse Lamellar Keratitis (DLK) covers another flap-interface complication that shares the same anatomical space.
The 3-Grade Classification of Epithelial Ingrowth
| Grade | Clinical Appearance | Visual Impact | Management |
|---|---|---|---|
| Grade 1 | Epithelial cells at flap edge only — thin peripheral rim, no ingrowth beyond 2mm from edge, no flap distortion | None — does not affect the visual axis or best corrected visual acuity (BCVA) | Observation only. Regular slit lamp monitoring. No surgery unless progression documented. |
| Grade 2 | Extends beyond 2mm from edge; may approach or enter the pupillary zone; mild flap elevation; grey-white opacity; epithelial “nests” or “pearls” on slit lamp | Mild irregular astigmatism; BCVA may reduce slightly; patient may report blurring or foreign body sensation | Surgical intervention typically recommended. Flap lift + debridement + adjuvant therapies (ethanol, MMC, fibrin glue). |
| Grade 3 | Extensive central visual axis ingrowth; significant flap opacity/distortion; possible early flap melt | Significant vision reduction; irregular astigmatism; blurring, photophobia, discomfort | Urgent surgical intervention — thorough debridement + all adjuvant therapies. Highest recurrence risk. |
Causes and Risk Factors
| Category | Risk Factor | Clinical Significance |
|---|---|---|
| Non-Modifiable (Patient) | Re-treatment / enhancement LASIK | Highest single risk factor — lifting a healed flap re-exposes the interface. Published rates up to 18–19% for re-LASIK vs 0.2–3.9% for primary LASIK. |
| Epithelial basement membrane dystrophy (EBMD) | EBMD causes weak epithelial adhesion — cells loosen more easily during flap creation and seed the interface at higher rates. Confirmed pre-operative risk factor in published series. | |
| Modifiable (Surgical / Behavioural) | Flap edge quality | Ragged or irregular edges (more common with microkeratome than femtosecond) leave more surface area for epithelial seeding. Femtosecond creates cleaner edges and a lower ingrowth rate. |
| Inadequate flap edge sealing | If the flap edge is not well-apposed post-operatively, a gap exists for cells to enter. Careful flap positioning at closure reduces this risk. | |
| Post-operative eye rubbing | Rubbing disturbs the flap edge and introduces surface cells into the interface. The primary reason patients are advised strictly against eye rubbing after LASIK. |
Our guide on LASIK flap repositioning covers the procedure and risk management for flap displacement.
Warning Signs — Normal Healing vs Epithelial Ingrowth vs Emergency
The most common question after LASIK: “How will I know if something is wrong?” This table distinguishes normal post-operative symptoms from warning signs that need a surgeon review:
| What You Notice | Most Likely Cause | What Grade? | Action |
|---|---|---|---|
| Mild dryness, grittiness, fluctuating blur — first 2 weeks | Normal healing — tear film instability as corneal nerves regenerate | Not ingrowth | Continue prescribed lubricating drops; follow standard post-op schedule |
| Vision improving, then blurring returns after Week 2–4 | Possible early epithelial ingrowth at the flap interface | Possible Grade 1–2 | Return for unscheduled slit lamp examination — do not wait for next scheduled appointment |
| Persistent foreign body sensation not improving beyond Week 1 | Possible early ingrowth or other flap-interface issue (DLK, flap fold) | Possible Grade 1 (requires assessment) | Report at next follow-up; if worsening, return sooner |
| Visible white/grey area near the flap edge | Epithelial cells at the flap margin — possible Grade 1 ingrowth | Likely Grade 1 | Return for slit lamp examination; photographs help track progression |
| Halos/glare from one direction (not symmetric) | Irregular astigmatism — ingrowth entering the visual axis | Likely Grade 2 | Urgent return — within days. Grade 2 progressing toward visual axis requires timely intervention. |
| Severe pain, sudden significant vision loss | Possible flap melt or infection | Grade 3 / Emergency | Same-day emergency review — do not wait or monitor at home |
How Epithelial Ingrowth Is Diagnosed
Most cases detected at routine slit lamp follow-up — often before the patient notices symptoms:
- Slit lamp examination: Primary detection tool — ingrowth appears as grey-white opacity, “pearls,” or “nests” at or beyond the flap edge; extent, grade, and flap distortion assessed.
- Anterior segment OCT: Cross-sectional imaging of the flap-stromal interface — shows precise location/depth of deposits and confirms flap structural integrity.
- Corneal topography/tomography: Detects irregular astigmatism — steepening or central map distortion may be the first clinical clue to Grade 2–3 ingrowth.
Our guide on post-LASIK ectasia diagnosis covers how these same tools differentiate other post-LASIK conditions.
Treatment Options for Epithelial Ingrowth — By Grade
| Treatment | How It Works | When Used |
|---|---|---|
| Observation only | Regular slit lamp follow-up at 1–3 month intervals; no surgery unless progression documented | Grade 1 — peripheral, non-progressive; not affecting visual axis or BCVA |
| Flap lift and debridement | LASIK flap is surgically re-lifted; epithelial cells are mechanically scraped from both the stromal bed and the flap undersurface | Grade 2–3. The definitive treatment step — all adjuvant therapies are added to this, not instead of it |
| Ethanol application | Dilute ethanol loosens epithelial cell attachments on the stromal bed/flap undersurface, enabling more complete mechanical removal | Grade 2–3, used during debridement to improve removal completeness |
| Mitomycin C (MMC) | Antimetabolite that inhibits epithelial cell proliferation — brief application to the stromal bed post-debridement suppresses residual cell regrowth | Grade 2–3; particularly in higher recurrence-risk cases (re-treatment LASIK, EBMD patients) |
| Fibrin glue | Applied to the flap edge after repositioning — seals the interface and prevents re-seeding through the edge pathway | Grade 2–3; particularly with flap edge quality concerns or previous recurrence — provides mechanical barrier |
Conclusion
Epithelial ingrowth is manageable — most cases are Grade 1 and never require treatment. Grade 2–3 require surgical intervention; published recurrence rates (6–68%) make follow-up non-negotiable. Prevention: EBMD screening before surgery; femtosecond over microkeratome; no eye rubbing post-LASIK. Use the warning signs table above to identify symptoms that warrant early surgeon review. For patients where the flap-interface is a specific concern, SMILE Pro and Trans-PRK eliminate this complication category entirely.
Concerned about a post-LASIK symptom or considering re-treatment? Book a clinical assessment at Visual Aids Centre — our team manages LASIK complications including epithelial ingrowth with the full range of adjuvant therapies.
Frequently Asked Questions
What is epithelial ingrowth after LASIK?
Corneal surface cells (epithelial cells) migrate under the LASIK flap and grow in the flap-stromal interface. It is flap-specific — it cannot occur with SMILE Pro or Trans-PRK (no interface exists). Published incidence: 0.2–3.9% for primary LASIK; up to 18–19% for re-treatment LASIK where the healed flap is re-lifted.
Does all epithelial ingrowth need treatment?
No — Grade 1 (peripheral, non-progressive, not affecting the visual axis) requires only observation and slit lamp monitoring. Most Grade 1 cases never need surgery. Grades 2–3 require flap lift and debridement — they affect the visual axis and cause irregular astigmatism.
Can epithelial ingrowth recur after treatment?
Yes — published series report recurrence rates of 6–68% depending on technique and adjuvants used. MMC (to suppress residual cell proliferation) and fibrin glue (to seal the flap edge) are applied specifically to reduce recurrence risk. Close slit lamp follow-up after treatment is essential — early detection prevents progression to a more advanced grade.
Who is at highest risk for epithelial ingrowth?
Highest risk: re-treatment (enhancement) LASIK — rates up to 18–19% vs 0.2–3.9% for primary LASIK. Patients with EBMD are also significantly elevated risk (poor epithelial adhesion → more cell seeding during flap creation). Post-operative eye rubbing is the most important modifiable risk factor patients control.
Can epithelial ingrowth be prevented?
Risk reduction rather than complete prevention is the goal. Key measures: EBMD screening before LASIK; femtosecond over microkeratome (cleaner flap edges, lower ingrowth rates); careful flap repositioning; strict no eye rubbing post-LASIK; fibrin glue in high-risk cases. Patients for whom the flap-interface is a specific concern may be better suited to SMILE Pro or Trans-PRK, which eliminate the interface — and this complication — entirely.
